Trial intelligence / Profile preview

Sodium Oxybate for Sleep in Critically Ill Patients

NCT00744393Phase 2Withdrawn

Sponsor
Tufts Medical Center
Start
Oct 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium oxybate in sleep disorder, sponsored by Tufts Medical Center. Planned start Oct 2008; status: withdrawn.

02

Drugs

sodium oxybate
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT00744393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00744393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call